RadNet, Inc. (RDNT)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$57.27
-0.83%
Mkt Cap $4.47B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | $516.69M | $547.71M | +6.00% | $0.19 | $0.23 | +21.05% | — | — |
| Q4 2025 Nov 9, 2025 | $494.48M | $522.87M | +5.74% | $0.22 | $0.20 | -10.27% | — | — |
| Q3 2025 Aug 10, 2025 | $493.52M | $498.23M | +0.95% | $0.17 | $0.31 | +82.35% | — | — |
| Q2 2025 May 11, 2025 | $442.98M | $471.40M | +6.41% | -$0.17 | -$0.35 | -105.88% | — | — |
| Q1 2025 Feb 27, 2025 | $459.42M | $477.10M | +3.85% | $0.21 | $0.22 | +4.76% | — | — |
| Q4 2024 Nov 10, 2024 | $433.91M | $461.14M | +6.28% | $0.14 | $0.18 | +32.55% | — | — |
| Q3 2024 Aug 7, 2024 | $438.50M | $459.71M | +4.84% | $0.16 | $0.16 | +0.00% | — | — |
| Q2 2024 May 8, 2024 | $421.72M | $431.71M | +2.37% | -$0.09 | $0.07 | +177.78% | — | — |
| Q1 2024 Feb 29, 2024 | $420.91M | $420.38M | -0.13% | $0.11 | $0.20 | +81.82% | — | — |
| Q4 2023 Nov 8, 2023 | $412.11M | $401.97M | -2.46% | $0.06 | $0.14 | +133.33% | — | — |
| Q3 2023 Aug 8, 2023 | $390.72M | $403.71M | +3.33% | $0.07 | $0.24 | +242.86% | — | — |
| Q2 2023 May 9, 2023 | $371.34M | $390.56M | +5.18% | -$0.07 | -$0.08 | -14.29% | — | — |
| Q1 2023 Feb 28, 2023 | $347.27M | $383.88M | +10.54% | $0.15 | $0.11 | -26.67% | — | — |
| Q4 2022 Nov 9, 2022 | $348.92M | $350.04M | +0.32% | $0.16 | $0.09 | -43.75% | — | — |
| Q3 2022 Aug 9, 2022 | $348.94M | $354.38M | +1.56% | $0.05 | $0.15 | +200.00% | — | — |
| Q2 2022 May 9, 2022 | $333.46M | $341.77M | +2.49% | -$0.00 | -$0.15 | -4602.19% | — | — |
| Q1 2022 Mar 1, 2022 | $344.63M | $333.15M | -3.33% | $0.19 | $0.13 | -31.58% | — | — |
| Q4 2021 Nov 8, 2021 | $341.24M | $332.69M | -2.51% | $0.20 | $0.21 | +5.00% | — | — |
| Q3 2021 Aug 9, 2021 | $298.85M | $333.92M | +11.73% | $0.14 | $0.27 | +92.86% | — | — |
| Q2 2021 May 10, 2021 | $302.59M | $315.32M | +4.21% | -$0.05 | $0.04 | +180.00% | — | — |